Protective Effect of Intraoperative Parathyroid Gland Auxiliary Recognition System in Thyroid Malignant Tumor Operation
- Conditions
- Intraoperative MonitoringThyroid CancerParathyroid
- Interventions
- Device: Intraoperative parathyroid gland auxiliary recognition system
- Registration Number
- NCT04560426
- Lead Sponsor
- Fudan University
- Brief Summary
This intraoperative parathyroid gland auxiliary recognition system uses the principle of parathyroid gland autofluorescence to assist surgeons in accurately identifying and protecting parathyroid glands during surgery, reducing the possibility of postoperative hypoparathyroidism. This study will explore the protective effect of the parathyroid gland auxiliary recognition instrument on parathyroid function during thyroid malignant tumor surgery through reasonable grouping.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 200
- Patients with unilateral thyroid malignancies who require surgical treatment between the ages of 20-50.
- No history of neck surgery and radiotherapy.
- There is no evidence of parathyroid tumor invasion in preoperative imaging assessment.
- No abnormal calcium metabolism disease.
- No abnormalities in blood calcium and blood PTH before operation.
- No allergy to contrast agents.
- The patient or his agent signs an informed consent statement.
- Does not meet the entry criteria;
- Parathyroid glands were found to be invaded by tumor during operation and the parathyroid glands could not be preserved.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Naked eyes & Instrument assistance Intraoperative parathyroid gland auxiliary recognition system Identify the parathyroid glands through the experience of surgeons and assistance of instrument.
- Primary Outcome Measures
Name Time Method PTH 1 month after surgery Patients' serum PTH level at 1 month after surgery.
Serum Calcium level 1 month after surgery Patients' serum Calcium level at 1 month after surgery.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Fudan University Shanghai Cancer Center
🇨🇳Shanghai, Shanghai, China